molsidomine has been researched along with alprostadil in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (88.24) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butt, E; Geiger, J; Nolte, C; Sage, SO; Walter, U | 1 |
| Bowen, R; Haslam, RJ | 1 |
| Haslam, RJ; Maurice, DH | 1 |
| Darius, H; Fisch, A; Meyer, J; Michael-Hepp, J | 1 |
| Antunes, E; Bizeto, L; de Nucci, G; Mariani-Pedroso, SR; Zatz, R | 1 |
| Porst, H | 2 |
| Klän, R; Knispel, HH; Meier, T; Miller, K; Wegner, HE | 1 |
| Hönig-Liedl, P; Horstrup, K; Jablonka, B; Just, M; Kochsiek, K; Walter, U | 1 |
| Knispel, HH; Wegner, HE | 1 |
| Klän, R; Knispel, HH; Miller, K; Wegner, HE | 1 |
| Gladis-Villanueva, M; Schrör, K | 1 |
| Jonas, U; Schultheiss, D; Stief, CG; Truss, MC | 1 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
| Buvat, J; Lemaire, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
2 review(s) available for molsidomine and alprostadil
| Article | Year |
|---|---|
[Pharmacological therapy in erectile dysfunction--current standards and new viewpoint].
Topics: Alprostadil; Dosage Forms; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Molsidomine; Muscle Relaxation; Muscle, Smooth; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Vasodilator Agents | 1997 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
3 trial(s) available for molsidomine and alprostadil
| Article | Year |
|---|---|
Prostaglandin E1 versus linsidomine chlorhydrate in erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Cross-Over Studies; Erectile Dysfunction; Humans; Male; Medical History Taking; Middle Aged; Molsidomine; Single-Blind Method; Time Factors; Treatment Outcome; Vasodilator Agents | 1994 |
Prostaglandin E1 and the nitric oxide donor linsidomine for erectile failure: a diagnostic comparative study of 40 patients.
Topics: Adult; Aged; Alprostadil; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Molsidomine; Penile Erection; Vasodilator Agents | 1993 |
Efficacy of linsidomine chlorhydrate, a direct nitric oxide donor, in the treatment of human erectile dysfunction: results of a double-blind cross over trial.
Topics: Adult; Aged; Alprostadil; Cross-Over Studies; Double-Blind Method; Humans; Male; Middle Aged; Molsidomine; Nitric Oxide; Penile Diseases; Penile Erection; Piperazines; Vasodilator Agents | 1995 |
12 other study(ies) available for molsidomine and alprostadil
| Article | Year |
|---|---|
Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets.
Topics: Adenosine Diphosphate; Alprostadil; Blood Platelets; Calcium; Cell Compartmentation; Cyclic GMP; Cytoplasm; Humans; In Vitro Techniques; Ion Channel Gating; Kinetics; Molsidomine; Nitroprusside; Phosphoproteins; Protein Kinases; Receptors, Cell Surface; Thrombin; Vasodilator Agents | 1992 |
Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
Topics: Alprostadil; Animals; Blood Platelets; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Male; Molsidomine; Nitric Oxide; Purinones; Rabbits; Serotonin; Vasodilator Agents | 1991 |
Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Topics: Adenosine; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Cyclic AMP; Cyclic GMP; Enzyme Activation; Ferricyanides; Hemoglobins; In Vitro Techniques; Kinetics; Molsidomine; Nitroprusside; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinolones; Rabbits; Radioimmunoassay; Vasodilator Agents | 1990 |
Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Topics: Adenylyl Cyclases; Alprostadil; Blood Platelets; Cyclic AMP; Cyclic GMP; Drug Synergism; Enzyme Activation; Guanylate Cyclase; Humans; Iloprost; In Vitro Techniques; Molsidomine; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors | 1995 |
Dissimilarity between prostaglandin E1 and nitric oxide donors as potentiators of plasma exudation in the rabbit skin in vivo.
Topics: Alprostadil; Animals; Arginine; Bradykinin; Capillary Permeability; Edema; Exudates and Transudates; Histamine; Histamine Antagonists; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Nitroprusside; Rabbits; Skin; Vasodilator Agents | 1995 |
The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Molsidomine; Moxisylyte; Papaverine; Penile Induration; Phentolamine | 1995 |
Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
Topics: Adenosine Diphosphate; Alprostadil; Blood Platelets; Blood Proteins; Cell Adhesion Molecules; Colforsin; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; In Vitro Techniques; Kinetics; Membrane Proteins; Microfilament Proteins; Molsidomine; Nitroprusside; Phosphoproteins; Phosphoserine; Platelet Membrane Glycoproteins; Protein Kinases; Protein-Tyrosine Kinases; Serine; Vasodilator Agents | 1994 |
Effect of nitric oxide-donor, linsidomine chlorhydrate, in treatment of human erectile dysfunction caused by venous leakage.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Molsidomine; Nitric Oxide; Vascular Diseases; Vasodilator Agents; Veins | 1993 |
Synergistic inhibition of human polymorphonuclear function by prostaglandin E1 and linsidomine.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Cyclic AMP; Drug Synergism; Humans; Molsidomine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Respiratory Burst | 1996 |
[Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1].
Topics: Adult; Aged; Alprostadil; Data Interpretation, Statistical; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Injections; Male; Middle Aged; Molsidomine; Penis; Time Factors; Vasodilator Agents | 1998 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |